The post hoc analysis, which included the four SURMOUNT trials [1], compared tirzepatide with a placebo for up to 72 to 88 weeks in 4,677 adults (2,999 females, 1,678 males) living with obesity, highlighting potential sex differences in the response
When people stop taking these medications, most of the weight comes back
3 Among people with AF who lost 10% or more of their body weight, 45.5% were free of AF symptoms at five years without rhythm-control medication or ablation
(PubMed) Henkin RI, Patten BM, Re PK, Bronzert DA
Because tirzepatide can reduce your appetite, practicing portion control and eating mindfully will help you better recognize your bodys fullness cues
As intracellular GSH is exhausted, the GSH synthesis system will be activated accordingly, which would weaken the efficacy of GSH exhaustion-based cancer therapies in long-term treatment (Niu et al., 2021)